Abstract
Clinical trials of biodynamic digital holography in human esophageal cancer and canine B-cell lymphoma, performed within 24 hours of biopsy acquisition, have an accuracy of 90% identifying patients resistant to their prescribed chemotherapy. Translation of this biomedical optical technology to clinical laboratory services has the potential to transform personalized cancer care.
© 2018 The Author(s)
PDF ArticleMore Like This
David D. Nolte, Zhe Li, Honggu Choi, John Turek, and Shadia Jalal
CTu4B.7 Clinical and Translational Biophotonics (Translational) 2018
David Nolte, Ran An, and John Turek
EW1C.4 European Conference on Biomedical Optics (ECBO) 2021
David D. Nolte, John J. Turek, Daniela E. Matei MD, and Shadia Jalal MD
11073_18 European Conference on Biomedical Optics (ECBO) 2019